Stem Cell Trial Update: Feb. 7th, 2013

Senior members of the MSRCNY research staff have been in contact with congressional offices and with the Food and Drug Administration in pursuit of expediting the process of lifting the clinical hold on stem cell clinical trial activities and proceeding with the study. Although exigent circumstances in Washington, DC, have caused delays in setting a meeting, such a meeting will be held in the near future and its outcome as well as any other pertinent updates to the status of the stem cell trial will be posted in this space as soon as they have been determined.